General Information of This Metabolic Reaction (MR) (ID:
MR006894) |
Formula |
|
Reactant |
Lomitapide mesylate |
Product |
Lomitapide metabolite M3 |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 1A2 (CYP1A2)
|
DME Info
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Mephenytoin 4-hydroxylase (CYP2C19)
|
DME Info
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects. J Clin Pharmacol. 2016 Jan;56(1):47-55.
|
2 |
LABEL: JUXTAPID- lomitapide mesylate capsule
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.